T hrombolytic therapy represents part of a conjoint approach to achieving vascular reperfusion, based primarily on the use of fibrinolytic agents delivered systemically or directly into the offending thrombus and complemented by anticoagulation, antiplatelet, and even mechanical strategies. This review describes the properties and effects of thrombolytic agents and clinical results using these agents in major venous and arterial thrombotic disorders.